US2013011500A1PendingUtilityA1

Ginger Extract for Inhibiting the Fat-storage Function of Adipocytes and a Medication thereof

Assignee: LIU I-MINPriority: Jul 8, 2011Filed: Jul 8, 2011Published: Jan 10, 2013
Est. expiryJul 8, 2031(~4.9 yrs left)· nominal 20-yr term from priority
A61P 3/04A61K 36/9068A61K 36/9062A61K 2236/00
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

In the present invention, a ginger extract for inhibiting the fat-storage function of adipocytes and a medication thereof is disclosed, wherein the ginger extract is obtained form Alpinia galangal and Zingiber zerumbet.

Claims

exact text as granted — not AI-modified
1 . A ginger extract for inhibiting the fat-storage function of adipocytes obtained by a process comprising steps of:
 drying, by providing roots or stems of  Alpinia galangal  and  Zingiber zerumbet,  followed by drying the roots or stems of  Alpinia galangal  and  Zingiber zerumbet  till water content of the roots or stems of  Alpinia galangal  and  Zingiber zerumbet  is lower than 10%, to obtain dry  Alpinia galangal  and dry  Zingiber zerumbet;      extracting, by preparing a ginger component by mixing the dry  Alpinia galangal  and the dry  Zingiber zerumbet  in a weight ration of 1:3 to 3:1 and then extracting the ginger component with a solvent to obtain a liquid extract; and   condensation, by condensing the liquid extract to obtain a ginger extract being capable of inhibiting the fat-storage function of adipocytes.   
     
     
         2 . The ginger extract for inhibiting the fat-storage function of adipocytes as defined in  claim 1 , wherein the solvent in the step of extracting is one of water, methanol ethanol acetone, ethane, propane, butane and hexane. 
     
     
         3 . The ginger extract for inhibiting the fat-storage function of adipocytes as defined in  claim 1 , wherein the weight ratio between the ginger component and the solvent in the step of extracting is 1:8 to 1:12. 
     
     
         4 . The ginger extract for inhibiting the fat-storage function of adipocytes as defined in  claim 1 , wherein the step of extracting is processed via sonication. 
     
     
         5 . The ginger extract for inhibiting the fat-storage function of adipocytes as defined in  claim 1 , wherein the step of drying is processed via lyophilization, spray drying, evaporation or heating drying. 
     
     
         6 . The ginger extract for inhibiting the fat-storage function of adipocytes as defined in  claim 1 , wherein the step of condensation is processed via evaporation or heating drying. 
     
     
         7 . A medication for inhibiting the fat-storage function of adipocytes, comprising:
 a ginger extract as defined in  claim 1 ; and   a medical acceptable excipient.   
     
     
         8 . The medication for inhibiting the fat-storage function of adipocytes as defined in  claim 7 , wherein the medication is oral medicament. 
     
     
         9 . The medication for inhibiting the fat-storage function of adipocytes as defined in  claim 7 , wherein the medication is in the form of a pill, pastil, powder, capsule or solution. 
     
     
         10 . The medication for inhibiting the fat-storage function of adipocytes as defined in  claim 7 , wherein a dosage of the medication is 300 to 600 mg/per kilogram of body.

Join the waitlist — get patent alerts

Track US2013011500A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.